The Oncology Brothers, joined by key opinion leader Stephanie Graff, MD, FACP, review clinical data from three key studies in breast cancer management and consider how they will impact the broader treatment landscape.
EP. 1: Adjuvant Ribociclib With Endocrine Therapy in HR+ Breast Cancer: The NATALEE Trial
Expert oncologist Stephanie Graff, MD, FACP, joins the Oncology Brothers to review data from the NATALEE trial and consider the role of adjuvant ribociclib in patients with HR+ breast cancer.
EP. 2: Determining the Role of Combination CDK4/6i + AI Therapy in HR+ mBC: The SONIA Trial
Shared insight from the Oncology Brothers and Stephanie Graff, MD, FACP, on the role of CDK4/6 inhibition in combination with aromatase inhibitor therapy following data from the SONIA trial in HR+ metastatic breast cancer.
EP. 3: Fixed-Dose Capecitabine in Metastatic Breast Cancer: The X-7/7 Trial
The Oncology Brothers, joined by Stephanie Graff, MD, FACP, share their thoughts on data from the X-7/7 trial of fixed-dose capecitabine in patients with metastatic breast cancer.
EP. 4: Key Takeaways: The Evolving Treatment Landscape of Breast Cancer Management
Following their interview with Stephanie Graff, MD, FACP, the Oncology Brothers share key takeaways from the NATALEE, SONIA, and X-7/7 trials and consider how they will impact the management of breast cancer.
2 Clarke Drive Cranbury, NJ 08512